STOCK TITAN

BGM Group Ltd. (BGM) Financials

BGM
FY2025 annual
Revenue $37.9M +51.1% YoY
Net Income -$19.9M -1282.1% YoY
EPS (Diluted) -$0.18 YoY not available
Free Cash Flow -$3.9M -1395.3% YoY
Market Cap $136.2M as of Oct 12, 2026
Price / Sales 3.6x on $37.9M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 0.3x on $390.9M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Sep 30, 2025 Reported Currency USD FYE September

Newest figures come from the 20-F for FY2025, filed Jul 21, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BGM SEC filings page.

BGM Group Ltd. (BGM) reported $37.9M in revenue for fiscal year 2025, up 51.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BGM FY2025

FY2025's revenue recovered, but overhead and goodwill reshaped the business into a larger-asset company still consuming cash.

Revenue recovered to $37.9M in FY2025, but SG&A reached $18.2M, so the rebound was absorbed by overhead rather than converted into operating profit. Operating cash flow was -$2.4M while net loss was $19.9M, showing that the accounting loss was accompanied by cash use, not merely non-cash charges.

The asset base expanded to $433.8M while goodwill alone reached $350.8M, making reported assets unusually dependent on an intangible balance rather than operating scale. Current ratio dropped to 1.2x from 3.4x in FY2024, so near-term liquidity tightened even without a debt-heavy structure.

Gross margin held near 16% across FY2024 and FY2025, but operating margin fell to -33.2%; this points to overhead, rather than direct production cost, as the main deterioration. Free cash flow turned negative at -$3.9M, even though reported liquidity equaled 107.8 months of the latest annual operating outflow; that pairing separates balance-sheet capacity from current cash generation.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 28 / 100
Financial Health Score 28/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of BGM Group Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
75

BGM Group Ltd. held $21.3M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $2.4M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and BGM Group Ltd. scores 75/100 among other emerging companies.

Dilution
8

BGM Group Ltd. had 201M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and BGM Group Ltd. scores 8/100 among other emerging companies.

R&D Intensity
11

BGM Group Ltd. spent $673K on research and development in fiscal year 2025, which was 1.3% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and BGM Group Ltd. scores 11/100 among other emerging companies.

Revenue Progress
31

BGM Group Ltd. reported revenue of $37.9M in fiscal year 2025, against $25.1M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and BGM Group Ltd. scores 31/100 among other emerging companies.

Burn Trend
0

Not available for BGM Group Ltd., and counted as zero in the overall score.

Balance Sheet
44

BGM Group Ltd.'s cash, cash equivalents and investments came to $21.3M at the end of fiscal year 2025, against $41.9M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and BGM Group Ltd. scores 44/100 among other emerging companies.

Altman Z-Score Grey Zone
1.92

BGM Group Ltd. scores 1.92, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($136.2M) relative to total liabilities ($41.9M). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
2/8

BGM Group Ltd. passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

BGM Group Ltd. reported a net loss of $19.9M while operations used $2.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$9.8M
YoY0.0%
QoQ+1.7%

BGM Group Ltd. held $9.8M in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding
201M

BGM Group Ltd. had 201M shares outstanding in Q4 2025.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

BGM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BGM quarterly income statement
MetricQ4'2520-FQ2'2510-QQ4'2420-FQ2'2410-QQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

BGM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BGM quarterly balance sheet
MetricQ4'2520-FQ2'2510-QQ4'2420-FQ2'2410-QQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-K
Total Assets$433.8M+718.5%$207.4M+316.0%$53.0M+3.4%$49.9M$51.3M-20.6%$64.5M-14.4%$75.4M+56.5%$48.1M+36.5%
Current Assets$51.5M+73.2%$42.9M+28.9%$29.8M-13.7%$33.3M$34.5M+14.9%$30.0M-25.6%$40.4M+7.6%$37.5M+50.3%
Cash & Equivalents$9.8M0.0%$9.7M-6.7%$9.8M+31.3%$10.3M$7.5M-47.8%$14.3M+36.8%$10.5M-11.8%$11.9M+158.3%
Short-Term Investments$0$0$0-100.0%$0$1.0M$0$0$0
Inventory$20.1M+298.1%$8.8M+90.3%$5.0M+1.2%$4.7M$5.0M-43.8%$8.9M-28.9%$12.5M+4.2%$12.0M-4.2%
Accounts Receivable$4.3M+175.6%$5.5M+669.8%$1.5M-21.9%$717K$2.0M+142.3%$815K-53.0%$1.7M+55.0%$1.1M+85.3%
Long-Term Investments$11.5M+242.1%$3.2M$3.4M+454.4%$0$606K-1.9%$618K-3.4%$639K+18.3%$541K+0.2%
Goodwill$350.8M$135.2MN/AN/AN/AN/AN/AN/A
Total Liabilities$41.9M+370.4%$23.9M+384.7%$8.9M+29.0%$4.9M$6.9M-27.8%$9.6M-48.8%$18.7M-3.2%$19.3M+52.8%
Current Liabilities$41.6M+374.0%$23.6M+398.7%$8.8M+31.8%$4.7M$6.7M-27.5%$9.2M-49.5%$18.2M-1.4%$18.4M+58.0%
Non-Current Liabilities$319K+137.7%$317K+56.8%$134K-45.5%$202K$246K-35.6%$382K-25.0%$510K-41.9%$878K-9.7%
Total Equity$390.9M+814.5%$182.1M+319.3%$42.7M-0.1%$43.4M$42.8M-19.3%$53.1M-3.3%$54.9M+110.2%$26.1M+31.2%
Retained Earnings-$15.8M-462.7%$3.5M-44.3%$4.3M-26.2%$6.3M$5.9M-62.0%$15.5M+5.5%$14.7M+20.5%$12.2M+61.3%

Not reported in any period shown, so not listed: Long-Term Debt.

BGM Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BGM quarterly cash flow statement
MetricQ4'2520-FQ2'2510-QQ4'2420-FQ2'2410-QQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

BGM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BGM quarterly financial ratios
MetricQ4'2520-FQ2'2510-QQ4'2420-FQ2'2410-QQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-K
Current Ratio1.24-2.2x1.82-5.2x3.39-1.8x7.055.18+1.9x3.27+1.1x2.22+0.2x2.04-0.1x
Debt-to-Equity0.11-0.1x0.130.0x0.210.0x0.110.160.0x0.18-0.2x0.34-0.4x0.74+0.1x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
BGM Group Ltd. BGM FY2025 $37.9M -$19.9M -52.6% $136.2M 28/100
Harrow, Inc. HROW FY2025 $272.3M -$5.1M -1.9% $1.1B 52/100
Phibro Animal Health Corporation PAHC FY2026 $1.5B $99.7M 6.6% $1.6B 60/100
Avadel Pharmaceuticals plc AVDL FY2024 $169.1M -$48.8M -28.9% $2.1B 53/100
Amphastar Pharmaceuticals, Inc. AMPH FY2025 $719.9M $98.1M 13.6% $1.1B 70/100
BioCryst Pharmaceuticals Inc BCRX FY2025 $874.8M $263.9M 30.2% $2.2B 74/100

Frequently Asked Questions

What is BGM Group Ltd.'s annual revenue?

BGM Group Ltd. (BGM) reported $37.9M in total revenue for fiscal year 2025. This represents a 51.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is BGM Group Ltd.'s revenue growing?

BGM Group Ltd. (BGM) revenue grew by 51.1% year-over-year, from $25.1M to $37.9M in fiscal year 2025.

Is BGM Group Ltd. profitable?

No, BGM Group Ltd. (BGM) reported a net income of -$19.9M in fiscal year 2025, with a net profit margin of -52.6%.

BGM Group Ltd. (BGM) reported diluted earnings per share of -$0.18 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

BGM Group Ltd. (BGM) had EBITDA of -$11.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

BGM Group Ltd. (BGM) had a gross margin of 16.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

BGM Group Ltd. (BGM) had an operating margin of -33.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

BGM Group Ltd. (BGM) had a net profit margin of -52.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

BGM Group Ltd. (BGM) has a return on equity of -5.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

BGM Group Ltd. (BGM) recorded an outflow of $3.9M in free cash flow during fiscal year 2025. This represents a -1395.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

BGM Group Ltd. (BGM) recorded an outflow of $2.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

BGM Group Ltd. (BGM) had $433.8M in total assets as of fiscal year 2025, including both current and long-term assets.

BGM Group Ltd. (BGM) invested $1.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

BGM Group Ltd. (BGM) invested $673K in research and development during fiscal year 2025.

BGM Group Ltd. (BGM) had 201M shares outstanding as of fiscal year 2025.

BGM Group Ltd. (BGM) had a current ratio of 1.24 as of fiscal year 2025, which is considered adequate.

BGM Group Ltd. (BGM) had a debt-to-equity ratio of 0.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

BGM Group Ltd. (BGM) had a return on assets of -4.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

BGM Group Ltd. (BGM) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $136.2M as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

BGM Group Ltd. (BGM) trades at 3.6x sales, its market capitalization divided by revenue of $37.9M revenue, FY2025. The market capitalization is $136.2M as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, BGM Group Ltd. (BGM) held $21.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.4M over that year. Dividing the one by the other, the reported balance equals about 108 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

BGM Group Ltd. (BGM) has an Altman Z-Score of 1.92, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

BGM Group Ltd. (BGM) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

BGM Group Ltd. (BGM) reported a net loss of $19.9M while operations used $2.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

BGM Group Ltd. (BGM) scores 28 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top